May 2026 $9 M No. 6 $2 to $10 million 43
Reprise Biomedical, Inc.: Raise no. 6, May 2026 × Investors in this round 43 investors had bought by the notice of Jul 1, 2026: 43 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $9 M of $10 M offered; $1 M still to sell
Smallest investment taken no minimum stated
What was sold equity Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
Estimates the notice marks sales commissions and payments to its own people as estimates
The company Corporation, incorporated in Minnesota People named in the notice Carrie Powers · Executive Officer, Director Greg Smock · Executive Officer Heather Kotila · Executive Officer Jake Isenburg · Executive Officer Jeff Duncan · Executive Officer Jerrod Krueger · Executive Officer Steve Jagodzinski · Executive Officer Tom Kouchoukos · Executive Officer Alan Woldt · Director Erwin Kelen · Director Howard Root · Director Phil Nalbone · Director Ronald Eibensteiner · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round Cedar Point Capital, LLC (CRD 145116) · broker-dealer Cedar Point Capital, LLC (CRD 145116) · Edina, Minnesota Sold in all US states Signed by Carrie Powers, Ceo. Source: SEC Form D, newest notice filed Jul 1, 2026. Read the notice at the SEC .
equity SEC Jun 2025 $6 M No. 5 $2 to $10 million 14
Reprise Biomedical, Inc.: Raise no. 5, Jun 2025 × Investors in this round 14 investors had bought by the notice of Jul 11, 2025: 14 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $6 M of $7 M offered; $1 M still to sell
Smallest investment taken no minimum stated
What was sold equity Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions $445,000
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
Estimates the notice marks sales commissions and payments to its own people as estimates
The company Corporation, incorporated in Minnesota People named in the notice Carrie Powers · Executive Officer, Director Greg Smock · Executive Officer Heather Kotila · Executive Officer Jake Isenburg · Executive Officer Jeff Duncan · Executive Officer Jerrod Krueger · Executive Officer Steve Jagodzinski · Executive Officer Tom Kouchoukos · Executive Officer Alan Woldt · Director Erwin Kelen · Director Howard Root · Director Phil Nalbone · Director Ronald Eibensteiner · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round Cedar Point Capital, LLC (CRD 145116) · broker-dealer Cedar Point Capital, LLC (CRD 145116) · Edina, Minnesota Sold in all US states Signed by Carrie Powers, Ceo. Source: SEC Form D, newest notice filed Jul 11, 2025. Read the notice at the SEC .
equity SEC Oct 2023 $8 M No. 4 $2 to $10 million 77
Reprise Biomedical, Inc.: Raise no. 4, Oct 2023 × Investors in this round 77 investors had bought by the notice of Dec 13, 2023: 77 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $8 M of $13 M offered; $5 M still to sell
Smallest investment taken no minimum stated
What was sold equity Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
Estimates the notice marks sales commissions as estimates
The company Corporation, incorporated in Minnesota People named in the notice Carrie Powers · Executive Officer, Director Greg Smock · Executive Officer Heather Kotila · Executive Officer Jake Isenburg · Executive Officer Jerrod Krueger · Executive Officer Steve Jagodzinski · Executive Officer Tina Walters · Executive Officer Erwin Kelen · Director Howard Root · Director Phil Nalbone · Director Ronald Eibensteiner · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round Cedar Point Capital, LLC · broker-dealer Cedar Point Capital, LLC (CRD 145116) · Edina, Minnesota Sold in all US states Remarks in the notice On fees: “Placement Agent to receive placement fee equal to 10% of gross proceeds of shares sold and legal fees up to a maximum aggregate amount of $25,000.”Signed by Carrie Powers, Ceo. Source: SEC Form D and 1 amendment, newest notice filed Dec 13, 2023. Read the notice at the SEC .
equity SEC Dec 2022 $15 M No. 3 $10 to $50 million 64
Reprise Biomedical, Inc.: Raise no. 3, Dec 2022 × Investors in this round 64 investors had bought by the notice of Jan 25, 2023: 64 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $15 M of $15 M offered
Smallest investment taken no minimum stated
What was sold equity Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Minnesota People named in the notice Carrie Powers · Executive Officer, Director Howard Root · Executive Officer, Director Erwin Kelen · Director Phil Nalbone · Director Phillip Nalbone · Director Ronald Eibensteiner · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by Carrie Powers, President & CEO. Source: SEC Form D and 1 amendment, newest notice filed Jan 25, 2023. Read the notice at the SEC .
equity SEC Nov 2020 $5 M No. 2 $2 to $10 million 39
Reprise Biomedical, Inc.: Raise no. 2, Nov 2020 × Investors in this round 39 investors had bought by the notice of Mar 31, 2021: 39 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $5 M of $5 M offered
Smallest investment taken no minimum stated
What was sold equity Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Minnesota People named in the notice Carrie Powers · Executive Officer, Director Howard Root · Executive Officer, Director Erwin Kelen · Director Jeff Ross · Director Ronald Eibensteiner · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by Carrie Powers, President & CEO. Source: SEC Form D and 1 amendment, newest notice filed Mar 31, 2021. Read the notice at the SEC .
equity SEC Jun 2019 $13 M No. 1 $10 to $50 million 51
Reprise Biomedical, Inc.: Raise no. 1, Jun 2019 × Investors in this round 51 investors had bought by the notice of Jul 12, 2019: 51 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $13 M of $13 M offered
Smallest investment taken no minimum stated
What was sold equity, options or other rights to buy securities Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Minnesota People named in the notice Carrie Powers · Executive Officer, Director · CEO and President Erwin Kelen · Director Howard Root · Director Jeff Ross · Director Ronald Eibensteiner · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by Carrie Powers, President and CEO. Source: SEC Form D, newest notice filed Jul 12, 2019. Read the notice at the SEC .
equity, options SEC